The FDA expanded the approval of mirikizumab (Omvoh) to include treatment of adults with moderately to severely active ...

Buying $1000 In LLY: If an investor had bought $1000 of LLY stock 15 years ago, it would be worth $21,118.25 today based on a ...

Scientists have discovered that inhaling xenon gas activates brain immune cells to break down Alzheimer 's-related plaques ...

The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely ...

The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

The fund is sponsored by Van Eck. It has amassed assets over $538.30 million, making it one of the larger ETFs attempting to match the performance of the Healthcare - Pharma segment of the equity ...

Laura Bolognesi is leading the B2AlzD2 Joint Lab at UNIBO, with Brazilian universities to develop Alzheimer's drugs from ...

With major U.S. lenders and investment banks’ earnings now turned in, one message from the wave of financial results is clear ...

Rounds reports on the FDA banning red dye no. 3 and curbing nicotine levels; a study showing meat associated with dementia ...

Access this story and all of our content 24/7 for $4.99 for 4 weeks. Continue for $14.99 for each additional 4 weeks.

Magnolia Middle School has released its honor roll for the second nine-week period of the 2024-2025 academic year.

Wockhardt’s experimental drug, Zaynich, has shown impressive results, achieving a 100% cure rate in clinical trials for ...